Company / Gross Profit
Thermo Fisher Scientific Gross Profit History
FY2016-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$2.6B
FY2018
5-year range
-
FY2016-FY2018
Trend
+17.7%
vs FY2017
Sector context
#22 of 100
Health Care
What the data says
Thermo Fisher Scientific's gross profit of $2.6B is higher than 78% of companies in the Health Care sector (FY2018). Improved from $2.0B to $2.6B over the past 2 years.
Based on SEC 10-K filings.
$2.6B in FY2018. Top quartile in the Health Care sector.
Improved from $2.0B to $2.6B over the past 2 years.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 22% in Health CareTop 22% of 100This company $2.6B Sector average $1.8B
▼
+42.1% above sector average
Key checks
Key Insights
- In FY2018, gross profit increased 17.7% year-over-year.
- Ranks #22 out of 100 companies in the Health Care sector.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | $2.6B | +17.7% |
| FY2017 | $2.2B | +12.0% |
| FY2016 | $2.0B | +7.4% |
As of FY2018 · SEC 10-K · Updated Jun 30, 2026